PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $40,115,000 | +62.4% | 1,172,943 | -15.9% | 0.84% | +74.5% |
Q3 2021 | $24,702,000 | -59.6% | 1,394,000 | +2.3% | 0.48% | -55.6% |
Q2 2021 | $61,162,000 | +87.6% | 1,362,790 | +8.3% | 1.09% | +58.5% |
Q1 2021 | $32,603,000 | +17.2% | 1,258,790 | -8.8% | 0.68% | +24.5% |
Q4 2020 | $27,820,000 | +20.6% | 1,379,971 | +16.9% | 0.55% | -2.1% |
Q3 2020 | $23,068,000 | +28.9% | 1,179,971 | +16.4% | 0.56% | +7.9% |
Q2 2020 | $17,898,000 | +282.4% | 1,013,495 | +350.4% | 0.52% | +183.2% |
Q4 2017 | $4,680,000 | – | 225,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |